Eisai and Biogen’s Alzheimer’s disease therapy Leqembi is due to be launched in Japan, its second market, on 20th December, and will be priced quite a lot lower there than in the US.

Eisai has been steadily building up expertise in the use of digital health systems to support people with dementia but has now gone one step further – launching a dedicated subsidiary company to ...

A white button-down shirt is just about as versatile as a piece of clothing gets. What else works equally well for a job interview, a late-night drink, and over a bikini? That said, sometimes you ...

Eisai now expects Leqembi sales to total 42.5 billion yen ($279 million), around 3 billion kronor ($278 million) for the period, down from 56.5 billion yen announced in May. This would generate ...

There are 305 results, Your applied filters are, colour white, ...